군유전체학 시장 규모, 점유율, 예측, 동향 분석 : 제공별, 기술별, 용도별 세계 예측(-2031년)

Metagenomics Market Size, Share, Forecast & Trends Analysis by Offering (Consumable, Instruments, Software), Technology (16S, Shotgun, Whole Genome Sequencing Microbial Sequencing), Application (Environmental, Clinical, Drug Discovery) - Global Forecast to 2031

The global metagenomics market is projected to reach $6.71 billion by 2031 at a CAGR of 15.6% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global metagenomics market is driven by decreasing sequencing cost, increasing focus on Agri genomics, expansion of F&B industry, and surge in genome mapping programs. However, high cost of instruments and regulatory and standardization concerns are restraining the market's growth.

Furthermore, rising adoption of bioinformatics and genomic data management solutions and government initiatives supporting large-scale genomic sequencing projects are expected to generate market growth opportunities. However, data storage, handling, interpretation, and confidentiality concerns and lack of skilled professionals are major challenges in the global autoinjector market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over years (2021-2024). The key players operating in the metagenomics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pacific Biosciences of California Inc. (U.S.), QIAGEN N.V. (Netherlands), Revvity, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Takara Bio, Inc. (Japan), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), 10X GENOMICS, INC. (U.S.), Promega Corporation (U.S.), Cantata Bio, LLC, and Zymo Research Corporation (U.S.).

Among all the offerings studied in this report, the consumables segment is projected to register the highest CAGR of 16.3% during the forecast period. The high CAGR of the segment is attributed to the recurring use of consumables and the rising demand for microbial gene profiling are driving the demand for consumables in the metagenomics market. Kits and regents are widely used for microbial gene profiling as it requires a high volume of samples and repetitive procedures.

Among all the technologies studies in this report, in 2024, 16S sequencing segment is accounted for the larger share of 39.5%. The rising focus on understanding the human microbiome and microbial communities in various environments has led to increased demand for techniques such as 16S sequencing. 16S sequencing helps in identifying new bioactive compounds in environmental samples, advances drug discovery and biotechnological applications. The increasing usage of 16S sequencing by microbiologists is contributing to the growth of largest share of the segment.

Among all the applications studied in this report, in 2024, environmental application segment is accounted for the largest share of 26.6%. The segment's larger share can be attributed to the rapid industrialization, urbanization, and agricultural activities. Growing urbanization and industrialization have resulted in the production and release of a variety of harmful organic and inorganic pollutants into the environment. These harmful substances build up and survive for lengthy periods, degrading the surrounding environment. This creates a demand for metagenomic solutions for environmental research purposes.

An in-depth analysis of the geographical scenario of the global metagenomics market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is projected to register the highest CAGR of 16.9% during the forecast period. The fastest growth of the market is due to the growing focus on the development of personalized medicines and increasing research activities in the field of microbial genomics are driving the demand for metagenomics products in the region. Additionally, advancements in sequencing technology and declining cost of sequencing technology are further expected to drive the metagenomics market in the region.

Scope of the Report:

Metagenomics Market Assessment-by Offering

• Consumables
• Instruments
• Software & Services
• Sequencing & Data Analysis Services

Metagenomics Market Assessment-by Technology

• 16S Sequencing
• Shotgun Metagenomic Sequencing
• Whole Genome Sequencing
• Other Technologies

(Note: Other technologies include targeted microbial sequencing, meta transcriptome sequencing, and pyrosequencing.)

Metagenomics Market Assessment-by Application

• Environmental Applications
• Clinical Diagnostics
• Drug Discovery
• Biotechnology
• Other Applications

(Note: Other applications include food & nutrition, agriculture & soil health, marine microbiomes, and extremophiles.)

Metagenomics Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Market Definition & Scope

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection And Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews With Key Opinion Leaders From The Industry
• 2.3. Market Sizing And Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions For The Study

3. Executive Summary

4. Factors Affecting Market Growth

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Decreasing Costs of Sequencing
  • 4.2.2. Increasing Focus on Agrigenomics
  • 4.2.3. Growth in Genome Mapping Programs
• 4.3. Restraints
  • 4.3.1. High Instrument Costs
  • 4.3.2. Regulatory & Standardization Concerns
• 4.4. Opportunity
  • 4.4.1. Rising Adoption of Bioinformatics & Genomics Data Management Solutions
  • 4.4.2. Government Initiatives Supporting Large Scale Genomic Sequencing Projects
• 4.5. Challenges
  • 4.5.1. Data Storage, Handling, Interpretation and Confidentiality Concerns
• 4.6. Trends
  • 4.6.1. Automation in Sequencing Technology
  • 4.6.2. Portable Sequencing Instruments
• 4.7. Porter's Five Forces Analysis

5. Metagenomics Market Assessment-By Offering

• 5.1. Overview
• 5.2. Consumbles
• 5.3. Instruments
• 5.4. Software & Services

6. Metagenomics Market Assessment-By Technology

• 6.1. Overview
• 6.2. 16S Sequencing
• 6.3. Shotgun Sequencing
• 6.4. Whole Genome Microbial Sequencing
• 6.5. Other Technologies

7. Metagenomics Market Assessment-By Application

• 7.1. Overview
• 7.2. Environmental Applications
• 7.3. Clinical Diagnostics
• 7.4. Drug Discovery
• 7.5. Biotechnology
• 7.6. Other Applications

8. Metagenomics Market Assessment-By Geography

• 8.1. Overview
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. Uk
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Rest of Europe (Roe)
• 8.4. Asia-Pacific
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Rest of Asia-Pacific (Roapac)
• 8.5. Latin America
• 8.6. Middle East & Africa

9. Competition Analysis

• 9.1. Overview
• 9.2. Key Growth Strategies
• 9.3. Competitive Benchmarking
• 9.4. Competitive Dashboard
  • 9.4.1. Industry Leaders
  • 9.4.2. Market Differentiators
  • 9.4.3. Vanguards
  • 9.4.4. Emerging Companies
• 9.5. Market Share/Ranking Analysis, By The Key Players, 2023

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, And Swot Analysis*)

• 10.1. Illumina, Inc. (U.S.)
• 10.2. Thermo Fisher Scientific Inc. (U.S.)
• 10.3. F. Hoffman-La-Roche Ltd (Switzerland)
• 10.4. Pacific Biosciences of California Inc. (U.S.)
• 10.5. QIAGEN N.V. (Netherlands)
• 10.6. Revvity, Inc. (U.S.)
• 10.7. Oxford Nanopore Technlogies PLC (U.K.)
• 10.8. Takara Bio, Inc. (Japan)
• 10.9. Bio-Rad Laboratories, Inc. (U.S.)
• 10.10. Agilent Technologies, Inc. (U.S.)
• 10.11. 10X Genomics, Inc. (U.S.)
• 10.12. Promega Corporation (U.S.)
• 10.13. Cantata Bio, LLC (U.S.)
• 10.14. Zymo Research Corporation (U.S.)

(Note: Swot Analysis* Will Be Provided of The Top 5 Companies)

11. Appendix

• 11.1. Available Customization
• 11.2. Related Reports